(Q37825664)

23 August 2017

1 reference

title

Hepatocyte growth factor twenty years on: Much more than a growth factor (English)

1 reference

23 August 2017

Takahiro Nakamura

1

1 reference

23 August 2017

Katsuya Sakai

series ordinal

2

1 reference

23 August 2017

Toshikazu Nakamura

series ordinal

3

1 reference

23 August 2017

Kunio Matsumoto

series ordinal

4

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Journal of Gastroenterology and Hepatology

23 August 2017

published in

1 reference

23 August 2017

volume

26 Suppl 1

1 reference

23 August 2017

page(s)

188-202

1 reference

Emerging multipotent aspects of hepatocyte growth factor

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Anti-cancer approach with NK4: Bivalent action and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1111/J.1440-1746.2010.06549.X

1 reference

23 August 2017

1 reference